S. Calderon

发表

Opioid peptide receptor studies. 9. Identification of a novel non-μ- non-δ-like opioid peptide binding site in rat brain

K. Rice, R. Rothman, Heng Xu, 1998, Peptides.

A regulatory perspective on the evaluation of hallucinogen drugs for human use

S. Calderon, J. Hunt, M. Klein, 2017, Neuropharmacology.

Rat natural killer cell, T cell and macrophage functions after intracerebroventricular injection of SNC 80.

K. Rice, R. Gomez-flores, R. Weber, 1998, The Journal of pharmacology and experimental therapeutics.

Human delta opioid receptor: functional studies on stably transfected Chinese hamster ovary cells after acute and chronic treatment with the selective nonpeptidic agonist SNC-80.

V. Hruby, R. Knapp, H. Yamamura, 1996, The Journal of pharmacology and experimental therapeutics.

Opioid peptide receptor studies. 4. Antisense oligodeoxynucleotide to the delta opioid receptor delineates opioid receptor subtypes

K. Rice, R. Rothman, Heng Xu, 1995, Regulatory Peptides.

Trends in dextromethorphan cough and cold products: 2000–2015 National Poison Data System intentional abuse exposure calls

S. Karami, J. Major, Jana K. McAninch, 2018, Clinical toxicology.

Chemistry of opioids

H. Nagase, S. Calderon, 2011 .

Probes for narcotic receptor mediated phenomena. 26. Synthesis and biological evaluation of diarylmethylpiperazines and diarylmethylpiperidines as novel, nonpeptidic delta opioid receptor ligands.

K. Rice, A. Coop, R. Rothman, 1999, Journal of medicinal chemistry.

Probes for Narcotic Receptor-Mediated Phenomena. 25.1 Synthesis and Evaluation of N-Alkyl-Substituted (α-Piperazinylbenzyl)benzamides as Novel, Highly Selective δ Opioid Receptor Agonists

Koichi Homma, Judith L. Flippen-Anderson, Richard B. Rothman, 1997 .

Probes for narcotic receptor mediated phenomena. 23.1 Synthesis, opioid receptor binding, and bioassay of the highly selective δ agonist (+)-4-[(αR)-α-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC 80) and related novel nonpeptide δ opioid receptor ligands

Robert Horvath, Judith L. Flippen-Anderson, Richard B. Rothman, 1997 .

Unexpected regioselectivity in the lithiation of fluoroanisoles

K. Kirk, George T. Chen, S. Calderon, 1988 .

Nonpeptidic Delta (δ) Opioid Agonists and Antagonists of the Diarylmethylpiperazine Class: What Have We Learned?

Silvia N. Calderon, S. Calderon, 2010 .

Rapid in vivo metabolism of a methylether derivative of (+/-)-BW373U86: the metabolic fate of [3H]SNC121 in rats.

C. M. Bertha, F. Porreca, J. Schetz, 1996, The Journal of pharmacology and experimental therapeutics.

SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist.

V. Hruby, R. Rothman, F. Porreca, 1995, The Journal of pharmacology and experimental therapeutics.

Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(alpha R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3- methoxybenzyl]-N,N-diethylbenzamide (SNC 80): a highly selective, nonpeptide delta opioid receptor agonist.

J. Flippen-Anderson, K. Rice, R. Rothman, 1994, Journal of medicinal chemistry.

Assessment of SNC 80 and Naltrindole Within a Conditioned Taste Aversion Design

A. Riley, K. Rice, Gregory R Simpson, 2000, Pharmacology Biochemistry and Behavior.

Regulatory Framework and Guidance to the Evaluation of the Abuse Liability of Drugs in the United States and Europe

A. Giarola, D. Heal, S. Calderon, 2015 .

Risk based in vitro performance assessment of extended release abuse deterrent formulations.

M. Khan, Abhay Gupta, Xiaoming Xu, 2016, International journal of pharmaceutics.

Convulsive Behavior of Nonpeptide δ-Opioid Ligands:Comparison of SNC80 and BW373U86 in Mice

K. Rice, J. Woods, J. Traynor, 1998 .

A regulatory perspective on the abuse potential evaluation of novel stimulant drugs in the United States

S. Calderon, M. Klein, 2014, Neuropharmacology.

Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors.

R. Knapp, G. Santoro, H. Yamamura, 1996, The Journal of pharmacology and experimental therapeutics.

Nonpeptidic delta (delta) opioid agonists and antagonists of the diarylmethylpiperazine class: what have we learned?

S. Calderon, 2011, Topics in current chemistry.

Probes for Narcotic Receptor Mediated Phenomena. Part 19. Synthesis of (+)-4-((αR)-α-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)- 3-methoxybenzyl)-N,N-diethylbenzamide (SNC 80): A Highly Selective, Nonpeptide δ Opioid Receptor Agonist.

J. Flippen-Anderson, K. Rice, R. Rothman, 1994 .

Novel 1-phenylcycloalkanecarboxylic acid derivatives are potent and selective sigma 1 ligands.

J. Gutkind, A. Newman, T. Su, 1994, Journal of medicinal chemistry.

Probes for narcotic receptor mediated phenomena 22. (1) synthesis and characterization of optically pure [3H](+)-4-[(αR)-α-((2S, 5R)-4-propyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N, N-diethylbenzamide, [3H]SNC 121, a novel high affinity and select

J. Gutkind, K. Rice, R. Rothman, 1996 .

Considerations in assessing the abuse potential of psychedelics during drug development

K. Bonson, C. Reissig, Joshua M Lloyd, 2022, Neuropharmacology.

Novel 1-phenylcycloalkanecarboxylic acid derivatives as potential anticonvulsant agents.

F. Tortella, A. Newman, S. Calderon, 1991, Journal of medicinal chemistry.

The third extracellular loop of the human delta-opioid receptor determines the selectivity of delta-opioid agonists.

V. Hruby, R. Knapp, H. Yamamura, 1996, Molecular pharmacology.